Tag #Gastrointestinal Diseases

What is the global health significance of Optiscan's new flexible endomicroscope, and what are the immediate implications of its pre-clinical trial?

Optiscan Imaging has launched a pre-clinical study in Germany for its second-generation flexible endomicroscope, designed to improve diagnosis and treatment of gastrointestinal diseases. The device provides real-time cellular-level imaging, potentially reducing the need for multiple biopsies. This collaboration with the University Medical Center of Johannes Gutenberg University aims to gather data for future clinical trials and the development of a third-generation device.